USFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen Ruchika Sharma27 Jan 2025 12:22 PM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental...
JnJ Posdinemab gets USFDA Fast Track Designation for treatment of Alzheimer's disease Ruchika Sharma9 Jan 2025 1:30 PM ISTPosdinemab is an investigational monoclonal antibody that targets the mid-domain of Alzheimer's disease-specific phosphorylated tau.
AbbVie concludes acquisition of Aliada Therapeutics Ruchika Sharma15 Dec 2024 10:00 AM ISTNorth Chicago, Ill: AbbVie has announced that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, Aliada...
AbbVie to acquire Aliada Therapeutics for USD 1.4 billion in cash Ruchika Sharma2 Nov 2024 1:00 PM ISTNorth Chicago: AbbVie and Aliada Therapeutics have announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology...
Eli Lilly Kisunla bags marketing authorization in Great Britain to treat mild cognitive impairment, mild dementia due to Alzheimer's Disease Ruchika Sharma30 Oct 2024 10:00 AM ISTIndianapolis: Eli Lilly and Company has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing...
Medical Bulletin 15/ October/ 2024 Dr. Bhumika Maikhuri15 Oct 2024 3:00 PM ISTHere are the top medical news for the day:1 in 4 Adults Suspect They Have Undiagnosed ADHDA new national survey of 1,000 American adults commissioned...
First sign of Alzheimer's linked to Quality of HDL in Women: Study Dr. Bhumika Maikhuri15 Oct 2024 8:45 AM ISTHigher levels of HDL-C-known as the "good cholesterol"-have been shown to correlate with heightened risk for Alzheimer's disease. A new study...
Eli Lilly Kisunla approved in Japan for early Symptomatic Alzheimer's disease Ruchika Sharma25 Sept 2024 3:54 PM ISTIndianapolis: Eli Lilly and Company's has announced that the Ministry of Health, Labour and Welfare Japan has approved Kisunla (donanemab-azbt,...
Medical Bulletin 07/ September/ 2024 Dr. Garima Soni7 Sept 2024 3:00 PM ISTHere are the top medical news for the dayStudy Links Nighttime Light Exposure to Increase Alzheimer's Risk in Adults Under 65In some places around the...
Glycated Hemoglobin A1c Levels and Dementia Risk in Older Diabetics: A New Perspective Dr. Nandita Mohan5 Aug 2024 8:15 AM ISTIndividuals with diabetes commonly experience Alzheimer's disease and related dementias (ADRD). Factors such as hypoglycemia, hyperglycemia, and...
Eli Lilly Kisunla gets USFDA okay for early Symptomatic Alzheimer's Disease Ruchika Sharma3 July 2024 11:20 AM ISTIndianapolis: Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has approved Alzheimer's treatment Kisunla...
USFDA Advisory Committee to convene meeting to discuss on Eli Lilly Alzheimer's drug donanemab Ruchika Sharma8 May 2024 4:30 PM ISTThe U.S. Food and Drug Administration (FDA) will convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee...
